Jefferson University Hospitals

Provider Profile

Edouard J. Trabulsi, MD, FACS

Jefferson University Physician

Academic Title: Professor
Co-Director, Multidisciplinary Genitourinary Oncology Center
Co-Director, Prostate Diagnostic Center
Vice Chair of Research, Department of Urology
Director, Division of Urologic Oncology, Department of Urology

Urology - Urologic Oncology

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

833 Chestnut Street
Suite 703
Philadelphia PA 19107
Phone: (215) 955-1000
Fax: (215) 503-2066

Medical Services

Years in Practice


Board Certifications

  • Urology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital

Awards and Honors

America's Top Doctors 2016,2015,2014,2013,2012,2011

Philadelphia Magazine's Top Docs 2017,2016,2015,2014,2013,2012,2011

America's Top Doctors for Cancer 2015,2014,2013,2012,2011,2010


  • SUNY at Buffalo School of Medicine, Medical School


  • Thomas Jefferson University Hospital


  • Thomas Jefferson University Hospital


  • Memorial Sloan-Kettering Cancer Center

Jefferson physicians accept most health insurance plans, including those listed below. However, plan acceptance may vary by practice and may be subject to change. If you have questions about whether a specific physician accepts your insurance, please contact your insurance company.

Insurances Accepted

  • Aetna
  • Aetna PA Employee Benefit Trust Fund (PEBTF)
  • Amer Assoc Retired Persons (AARP)
  • AmeriHealth
  • Amerihealth Caritas
  • AmeriHealth Comprehensive
  • AmeriHealth HMO
  • AmeriHealth Major Medical
  • AmeriHealth Personal Choice
  • BC BS Special Care
  • Blue Choice
  • Blue Cross/Blue Shield
  • Blue Cross/Blue Shield of Delaware
  • Cigna Healthspring
  • Cigna PPO, POS
  • Consumer Health Network PPO
  • CorVel
  • Coventry/Health America
  • Delaware Blue Cross/Blue Shield
  • Devon
  • Empire BC/BS
  • Employers Health Network PPO
  • Evolutions (Guardian Resources)
  • Federal BCBS
  • First Health Network
  • Galaxy
  • Geisinger Health Plan
  • Health America PPO
  • Health Management Network PPO
  • Horizon Blue Cross/Blue Shield
  • Horizon HMO
  • HumanaChoicePPO,Medicare,GoldPlusHMO
  • Inter-County Health Plan
  • Intergroup Preferred
  • Jeff Plus
  • Keystone 65 HMO
  • Keystone First VIP Choice
  • Keystone First/Connect
  • Keystone Health Plan East
  • Medallion of New Jersey
  • Medicaid of PA
  • Medicare
  • Mercy LIFE
  • MultiPlan Inc.
  • NJ Blue Shield
  • NJ Plus
  • Oxford of PA
  • Personal Choice (GPPPN)
  • Personal Choice 65
  • PlanCare America
  • Postal Workers/Mailhandlers
  • PPO Next
  • Preferred Care PPO
  • Premier Blue
  • Prime Health Services, Inc.
  • Private Healthcare Systems (PHCS)
  • Qualcare
  • Tricare
  • United Healthcare
  • UPMC HMO,PPO ReadingHspEmpONLY
  • UPMC Medicare HMO
  • US Family Health Plan

Recent Publications

VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen

Creation of a Novel Digital Rectal Examination Evaluation Instrument to Teach and Assess Prostate Examination Proficiency

Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer

Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study

Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017

Therapeutic Patterns and Barriers to the Treatment of Advanced Prostate Cancer: A Survey of Academic and Community Urologists in the United States

VAPC-1 Targeted64Cu-TP3805 kit preparation and its evaluation

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study

Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts

Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study

Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature

Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy

Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: The largest single-institution experience to date

Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies

Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy

Decipher correlation patterns post prostatectomy: Initial experience from 2 342 prospective patients

Clinical Influences in the Multidisciplinary Management of Small Renal Masses at a Tertiary Referral Center

Characterizing renal cell carcinoma ablation cavities using 3D contrast enhanced ultrasound time intensity curve analysis

Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report

Utilization of a Genomic Classifier for Prediction of Metastasis Following Salvage Radiation Therapy after Radical Prostatectomy